Hiroki Akiyama - AstraZeneca KK | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Cardiovascular, Renal and Mortality Risk by the KDIGO Heatmap in Japan

Shoichi Maruyama,Tetsuhiro Tanaka,Hiroki Akiyama, Mitsuru Hoshino,Shoichiro Inokuchi, Shuji Kaneko, Koji Shimamoto, Asuka Ozaki

Clinical Kidney Journal (2024)

引用0浏览0WOS引用

#1185 Cardiovascular, Renal and Mortality Risk by the KDIGO Risk Classification: the First Observational Study in Japan

Shoichi Maruyama,Hiroki Akiyama, Asuka Ozaki,Tetsuhiro Tanaka

NEPHROLOGY DIALYSIS TRANSPLANTATION (2024): I1017-I1019

引用0浏览0引用

Kidney Outcomes of SGLT2 Inhibitors among Older Patients with Diabetic Kidney Disease in Real-World Clinical Practice: the Japan Chronic Kidney Disease Database Ex

Kaori Kitaoka,Yuichiro Yano,Hajime Nagasu,Hiroshi Kanegae, Noriharu Chishima,Hiroki Akiyama,Kouichi Tamura,Naoki Kashihara

BMJ OPEN DIABETES RESEARCH & CAREno. 3 (2024)

引用0浏览0WOS引用

Treatment Patterns and Trajectories in Patients after Acute Heart Failure Hospitalization

Ryo Nakamaru,Yasuyuki Shiraishi,Takashi Kohno,Yuji Nagatomo,Hiroki Akiyama, Yuki Motoya, Masato Fukui,Toshitaka Yajima,Tsutomu Yoshikawa,Shun Kohsaka

ESC HEART FAILUREno. 2 (2024): 692-701

引用0浏览0WOS引用

Population Characteristics and Diagnosis Rate of Chronic Kidney Disease by Egfr and Proteinuria in Japanese Clinical Practice: an Observational Database Study

Tetsuhiro Tanaka,Shoichi Maruyama, Noriharu Chishima,Hiroki Akiyama, Koji Shimamoto,Shoichiro Inokuchi, Keiji Yokota, Asuka Ozaki

SCIENTIFIC REPORTSno. 1 (2024)

引用0浏览0WOSNATURE引用

Evolution of Sodium-Glucose Co-Transporter 2 Inhibitors from a Glucose-Lowering Drug to a Pivotal Therapeutic Agent for Cardio-Renal-metabolic Syndrome

Hiroki Akiyama,Akihiro Nishimura,Naru Morita,Toshitaka Yajima

FRONTIERS IN ENDOCRINOLOGY（2023）

引用4浏览0引用

#2622 COST-EFFECTIVENESS OF SGLT2 INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ITS COMPLICATIONS

Ataru Igarashi,Hisateru Tachimori,Keiko Maruyama-Sakurai,Anna Kubota, Yasumasa Segawa,Hiroki Akiyama,Naohiko Imai,Shun Kohsaka,Hiroaki Miyata

Nephrology, dialysis, transplantation/Nephrology dialysis transplantationno. Supplement_1 (2023)

引用0浏览0引用

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

Igarashi Ataru,Maruyama-Sakurai Keiko,Kubota Anna,Akiyama Hiroki,Yajima Toshitaka,Kohsaka Shun,Miyata Hiroaki

Diabetes Therapy（2022）

引用3浏览0WOS引用

Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment

Tomoya Mita,Naoto Katakami,Mitsuyoshi Takahara,Masaru Kawashima,Fumitaka Wada,Hiroki Akiyama,Naru Morita,Yoko Kidani,Toshitaka Yajima,Iichiro Shimomura,Hirotaka Watada

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM（2022）

引用2浏览0WOS引用

Manifestation of Heart Failure and Chronic Kidney Disease Are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database

Kadowaki Takashi,Komuro Issei,Morita Naru,Akiyama Hiroki,Kidani Yoko,Yajima Toshitaka

Diabetes Therapy（2022）

引用5浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn